Clinical and Experimental Study of the Effect of Xilixin Granule Combined with Radiotherapy on Malignant Tumors

Objective: To observe the effect of Xilixin Granule combined with radiotherapy in treating malignant tumors. Methods:Thirty six patients of pulmonary or nasopharyngeal carcinoma were treated with Xilixin granule (XLXG) combined with radiotherapy and compared their efficacy with that of 31 patients treatedby Zhenqi Fuzheng granule combined with radiotherapy for control. Results: The symptoms of YinDeficiency syndrome in the treated group were obviously improved, the leucocyte decreased by 5. 6%, while inthe control group it reached 25. 8%, the 3 year survival rate was significantly higher in the treated group (75.0%) than that in the control group (51. 6 % ). Animal experiment revealed that XLXG had the effects of tumorinhibition, it could Increase white blood cells, platelets and hemoglobin of patients, especially in using largedosage. Conclusion: XLXG have some protective effect against radiotherapeutic damage in patients with malignant tumor.

希力新冲剂对恶性肿瘤放射治疗的临床与实验观察

用希力新冲剂配合放射治疗鼻咽癌、肺癌３６例（治疗组），与放疗加贞芪扶正冲剂治疗３１例（对照组）比较，临床阴虚症状明显好转；治疗组的白细胞下降为５．６％，而对照组达２５．８％；３年存活率治疗组（７５．０％）明显优于对照组（５１．６％）。动物实验显示希力新冲剂对肿瘤有明显的抑制作用，对白细胞、血小板和血红蛋白均有提升作用，大剂量组尤为明显。提示希力新冲剂对恶性肿瘤的放射治疗损伤可能具有一定的防护作用。